Nikon, Inc.

Nikon, Inc. specializes in inverted-stage light microscopes, which are designed for detailed cellular and tissue imaging. These include models tailored for specific applications like in vitro fertilization (IVF) procedures, such as the ECLIPSE Ti2-U IVF and ECLIPSE Ti2-I, as well as systems for chromosome analysis like the NIKON/JOYCE LOCK MAGICAN 2 Chromosome System. The company also produces accessories like angle magnifying lenses for specialized imaging needs.

Nikon, Inc. is headquartered in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). Since the company manufactures medical devices regulated under FDA classifications—such as Class I and Class II—its products are subject to U.S. regulatory requirements, including potential listing under programs like the 510(k) pathway or UDI (Unique Device Identification).

Nikon, Inc.’s devices are included in U.S. regulatory databases such as the FDA’s 510(k) premarket notification program and the UDI (Unique Device Identification) system. These registries track devices that require FDA clearance or are subject to mandatory identification requirements, ensuring transparency and compliance with U.S. medical device regulations.

Nikon, Inc.’s devices are classified under FDA’s risk-based system, with most falling into Class I (low risk, generally exempt from premarket submission) or Class II (moderate risk, requiring special controls or 510(k) clearance). For example, inverted-stage microscopes like the ECLIPSE Ti2 series may be classified as Class II due to their role in critical procedures like IVF or chromosome analysis, requiring additional regulatory oversight to ensure safety and performance.

The FDA classifies devices based on their intended use and potential risk to patients. Class I devices, like basic microscopes, often require general controls (e.g., labeling, manufacturing practices) and may not need premarket submission unless they pose higher risks. In contrast, Class II devices—such as those used in reproductive procedures (e.g., IVF microscopes) or genetic analysis—require special controls or a 510(k) clearance to demonstrate they meet performance standards and mitigate risks, as these applications directly impact patient outcomes.